Schottky Junction Nanozyme Based on Mn-Bridged Co-Phthalocyanines and Ti 3 C 2 T x Nanosheets Boosts Integrative Type I and II Photosensitization for Multimodal Cancer Therapy
ACS Nano · 2023
DOI: 10.1021/acsnano.2c12270 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Fenghe Duan und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Material and Chemical Engineering, Zhengzhou University of Light Industry, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, National Key Research and Development Program of China, Youth Innovation Promotion Association of the Chinese Academy of Sciences.
Abstract (Originalsprache)
Cancer phototheranostics have the potential for significantly improving the therapeutic effectiveness, as it can accurately diagnose and treat cancer. However, the current phototheranostic platforms leave much to be desired and are often limited by tumor hypoxia. Herein, a Schottky junction nanozyme has been established between a manganese-bridged cobalt-phthalocyanines complex and Ti3C2Tx MXene nanosheets (CoPc-Mn/Ti3C2Tx), which can serve as an integrative type I and II photosensitizer for enhancing cancer therapeutic efficacy via a photoacoustic imaging-guided multimodal chemodynamic/photothermal/photodynamic therapy strategy under near-infrared (808 nm) light irradiation. The Schottky junction not only possessed a narrow-bandgap, enhanced electron-hole separation ability and exhibited a potent redox potential but also enabled improved H2O2 and O2 supplying performances in vitro. Accordingly, the AS1411 aptamer-immobilized CoPc-Mn/Ti3C2Tx nanozyme illustrated high accuracy and excellent anticancer efficiency through a multimodal therapy strategy in in vitro and in vivo experiments. This work presents a valuable method for designing and constructing a multifunctional nanocatalytic medicine platform for synergistic cancer therapy of solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Material and Chemical Engineering, Zhengzhou University of Light Industry, Zhengzhou 450001, China.
- Departments of Bioengineering and Chemistry, Rice University, Houston, Texas 77005, United States.
- CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
ORCID-Profile: Lihong Jing, Zhihong Zhang
Förderung
- Natural Science Foundation of Henan Province
- National Key Research and Development Program of China
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Duan, F., Jia, Q., Liang, G., Wang, M., Zhu, L., McHugh, K. J., Jing, L., Du, M., & Zhang, Z. (2023). Schottky Junction Nanozyme Based on Mn-Bridged Co-Phthalocyanines and Ti 3 C 2 T x Nanosheets Boosts Integrative Type I and II Photosensitization for Multimodal Cancer Therapy. ACS Nano. https://doi.org/10.1021/acsnano.2c12270
Vancouver
Duan F, Jia Q, Liang G, Wang M, Zhu L, McHugh KJ, et al. Schottky Junction Nanozyme Based on Mn-Bridged Co-Phthalocyanines and Ti 3 C 2 T x Nanosheets Boosts Integrative Type I and II Photosensitization for Multimodal Cancer Therapy. ACS Nano. 2023. doi:10.1021/acsnano.2c12270
BibTeX
@article{Duan2023,
author = {Duan, Fenghe and Jia, Qiaojuan and Liang, Gaolei and Wang, Mengfei and Zhu, Lei and McHugh, Kevin J and Jing, Lihong and Du, Miao and Zhang, Zhihong},
title = {Schottky Junction Nanozyme Based on Mn-Bridged Co-Phthalocyanines and Ti 3 C 2 T x Nanosheets Boosts Integrative Type I and II Photosensitization for Multimodal Cancer Therapy},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.2c12270}
}
EUVIMED